Abstract
Background: Sphingomonas paucimobilis is an emerging opportunistic pathogen associated with hospital and community-acquired infections. Infection is the most common cause of morbidity and mortality in burn patients.
Case Presentation: We present a case of a 29-year-old lady who sustained severe burn injuries after a gas explosion at home. She was admitted to the United Arab Emirates (UAE) National Burns Unit and required several episodes of surgical debridement. She developed S. paucimobilis bloodstream infection whilst being treated with Piperacillin-tazobactam. She was subsequently treated with Meropenem for a total of 7 days after removing the source of infection, an infected central line. The S. paucimobilis isolate showed intermediate resistance to Piperacillin-tazobactam.
Conclusion: Numerous case reports indicate high morbidity in patients with life-threatening S. paucimobilis infections, immunocompromised patients, and patients with underlying medical comorbidity; however, this is the first reported case from the UAE.
Keywords: Sphingomonas paucimobilis, Central line-associated blood stream infections, Bacteremia, Hospital acquired, Major burns, Burns unit.
New Emirates Medical Journal
Title:Sphingomonas Paucimobilis Bacteremia in a Patient with Major Burns Injury: A Case Report
Volume: 5
Author(s): Afaf Al Maskari*, Ramesh Ganeshan, Ahmed Al Messabi, Hasan Al Zaabi, Noor Mohammad Abdul Haqu, Robert Lodu Serafino Wani, Zahir Babiker, Adnan Alatoom, Fouzia Jabeen and Emmanuel Fru Nsutebu
Affiliation:
- Education Institute, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
Keywords: Sphingomonas paucimobilis, Central line-associated blood stream infections, Bacteremia, Hospital acquired, Major burns, Burns unit.
Abstract:
Background: Sphingomonas paucimobilis is an emerging opportunistic pathogen associated with hospital and community-acquired infections. Infection is the most common cause of morbidity and mortality in burn patients.
Case Presentation: We present a case of a 29-year-old lady who sustained severe burn injuries after a gas explosion at home. She was admitted to the United Arab Emirates (UAE) National Burns Unit and required several episodes of surgical debridement. She developed S. paucimobilis bloodstream infection whilst being treated with Piperacillin-tazobactam. She was subsequently treated with Meropenem for a total of 7 days after removing the source of infection, an infected central line. The S. paucimobilis isolate showed intermediate resistance to Piperacillin-tazobactam.
Conclusion: Numerous case reports indicate high morbidity in patients with life-threatening S. paucimobilis infections, immunocompromised patients, and patients with underlying medical comorbidity; however, this is the first reported case from the UAE.
Export Options
About this article
Cite this article as:
Al Maskari Afaf*, Ganeshan Ramesh, Al Messabi Ahmed, Al Zaabi Hasan, Abdul Haqu Noor Mohammad, Serafino Wani Lodu Robert, Babiker Zahir, Alatoom Adnan, Jabeen Fouzia and Nsutebu Emmanuel Fru, Sphingomonas Paucimobilis Bacteremia in a Patient with Major Burns Injury: A Case Report, New Emirates Medical Journal 2024; 5 : e02506882262684 . https://dx.doi.org/10.2174/0102506882262684230928065501
DOI https://dx.doi.org/10.2174/0102506882262684230928065501 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Determinants of Paraoxonase 1 Status: Genes, Drugs and Nutrition
Current Medicinal Chemistry The Regulatory Mechanisms and Clinical Significance of Lnc SNHG4 in Cancer
Current Pharmaceutical Design Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology Hormones and their Receptors Bridge Fat and Bone Metabolisms
Current Signal Transduction Therapy Relationship Between Na<sup>+</sup>, K<sup>+</sup>-ATPase and NMDA Receptor at Central Synapses
Current Protein & Peptide Science Chronic Kidney Disease, Metabolic Syndrome, and Cardiovascular Risk: Insights and Associated Mechanistic Pathways
Current Nutrition & Food Science Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry Immune Responses to Adeno-Associated Virus Vectors
Current Gene Therapy Antiproliferative Activities on Renal, Prostate and Melanoma Cancer Cell Lines of Sarcopoterium spinosum Aerial Parts and its Major Constituent Tormentic Acid
Anti-Cancer Agents in Medicinal Chemistry Safe Utilization of Hyperglycemia Management in the ICU
Current Drug Safety Chlorogenic Acid: A Dietary Phenolic Acid with Promising Pharmacotherapeutic Potential
Current Medicinal Chemistry Anti-VEGF Therapy for Retinal Vein Occlusions
Current Drug Targets Differentiation of iNKT Cells from Embryonic Stem Cells
Current Immunology Reviews (Discontinued) Synthesis and Biological Activities of Naturally Functionalized Polyamines: An Overview
Current Medicinal Chemistry Preface
Endocrine, Metabolic & Immune Disorders - Drug Targets Three Generations of β-blockers: History, Class Differences and Clinical Applicability
Current Hypertension Reviews Low Testosterone Levels and Metabolic Syndrome in Aging Male
Current Pharmaceutical Design Synthesis and Anti-HIV-Evaluation of Novel Andrographolide Derivatives
Letters in Drug Design & Discovery Bioinformatics Analysis Identifies CPZ as a Tumor Immunology Biomarker for Gastric Cancer
Current Bioinformatics Structural Activity Relationship and Importance of Benzothiazole Derivatives in Medicinal Chemistry: A Comprehensive Review
Mini-Reviews in Organic Chemistry